​

NovaBridge Biosciences (NBP) Stock Forecast, Price Target & Predictions

OverviewFinancialsChart

NBP Stock Forecast

NovaBridge Biosciences (NBP) stock forecast, based on 11 Wall Street analysts, predicts a 12-month average price target of $7.75, with a high of $9.00 and a low of $7.00. This represents a 67.39% increase from the last price of $4.63.

- $1 $2 $3 $4 $5 $6 $7 $8 $9 High: $9 Avg: $7.75 Low: $7 Last Closed Price: $4.63

NBP Stock Rating

NovaBridge Biosciences stock's rating consensus is Buy, based on 11 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 11 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 11 0 11 Strong Sell Sell Hold Buy Strong Buy

NBP Price Target Upside V Benchmarks

TypeNameUpside
StockNovaBridge Biosciences67.39%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts-24
Avg Price Target-$8.00$7.75
Last Closing Price$4.63$4.63$4.63
Upside/Downside-72.79%67.39%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Dec, 25-5---5
Nov, 2514---5
Oct, 2525---7
Sep, 2524---6
Aug, 2523---5
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 27, 2025Andrew FeinH.C. Wainwright$7.00$4.5254.87%51.19%
Oct 03, 2025Leerink Partners$9.00$4.13117.92%94.38%
Sep 10, 2025New Street$7.00$4.1867.46%51.19%
Aug 28, 2025Kumaraguru RajaLoop Capital Markets$8.00$4.2588.24%72.79%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 27, 2025H.C. WainwrightBuyBuyhold
Sep 10, 2025BTIGBuyBuyhold
Sep 09, 2025BTIGBuyinitialise
Aug 28, 2025Brookline CapitalBuyBuyhold
Sep 16, 2024Piper SandlerOverweightOverweighthold
Mar 18, 2024Piper SandlerOverweightOverweighthold
Aug 17, 2022NeedhamBuyBuyhold
Jun 07, 2022Piper SandlerOverweightOverweighthold

Financial Forecast

EPS Forecast

$-20 $-16 $-12 $-8 $-4 $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$-17.62$-4.46-----
Avg Forecast$-11.53$-1.27$-2.46$-3.79$-3.05$-3.09$-1.60
High Forecast$-11.53$-1.27$-1.45$-2.58$-1.09$-3.09$-1.60
Low Forecast$-11.53$-1.27$-3.85$-5.59$-6.40$-3.09$-1.60
Surprise %52.82%251.18%-----

Revenue Forecast

$50M $100M $150M $200M $250M $300M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$4.49M------
Avg Forecast$26.27M----$53.27M$266.94M
High Forecast$26.27M----$53.27M$266.94M
Low Forecast$26.27M----$53.27M$266.94M
Surprise %-82.92%------

Net Income Forecast

$-2B $-1B $-900M $-600M $-300M $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$-1.47B$-162.26M-----
Avg Forecast$-936.22M$-102.71M$-297.96M$-331.54M$-513.01M$-250.57M$-129.54M
High Forecast$-936.22M$-102.71M$-117.98M$-209.62M$-88.73M$-250.57M$-129.54M
Low Forecast$-936.22M$-102.71M$-312.91M$-453.46M$-519.70M$-250.57M$-129.54M
Surprise %56.55%57.98%-----

NBP Forecast FAQ

Is NovaBridge Biosciences stock a buy?

NovaBridge Biosciences stock has a consensus rating of Buy, based on 11 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 11 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that NovaBridge Biosciences is a favorable investment for most analysts.

What is NovaBridge Biosciences's price target?

NovaBridge Biosciences's price target, set by 11 Wall Street analysts, averages $7.75 over the next 12 months. The price target range spans from $7 at the low end to $9 at the high end, suggesting a potential 67.39% change from the previous closing price of $4.63.

How does NovaBridge Biosciences stock forecast compare to its benchmarks?

NovaBridge Biosciences's stock forecast shows a 67.39% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for NovaBridge Biosciences over the past three months?

  • December 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • November 2025: 20.00% Strong Buy, 80.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • October 2025: 28.57% Strong Buy, 71.43% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is NovaBridge Biosciences’s EPS forecast?

NovaBridge Biosciences's average annual EPS forecast for its fiscal year ending in December 2025 is $-2.46, marking a -44.84% decrease from the reported $-4.46 in 2024. Estimates for the following years are $-3.79 in 2026, $-3.05 in 2027, $-3.09 in 2028, and $-1.6 in 2029.

What is NovaBridge Biosciences’s revenue forecast?

NovaBridge Biosciences's average annual revenue forecast for its fiscal year ending in December 2025 is $0, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $0, followed by $0 for 2027, $53.27M for 2028, and $266.94M for 2029.

What is NovaBridge Biosciences’s net income forecast?

NovaBridge Biosciences's net income forecast for the fiscal year ending in December 2025 stands at $-298M, representing an 83.63% increase from the reported $-162M in 2024. Projections indicate $-332M in 2026, $-513M in 2027, $-251M in 2028, and $-130M in 2029.